PortfoliosLab logoPortfoliosLab logo
SBIO vs. METL
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

SBIO vs. METL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ALPS Medical Breakthroughs ETF (SBIO) and Sprott Active Metals & Miners ETF (METL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SBIO achieves a -1.72% return, which is significantly lower than METL's 7.51% return.


SBIO

1D
-0.36%
1M
-9.33%
YTD
-1.72%
6M
-2.48%
1Y
59.38%
3Y*
16.69%
5Y*
1.33%
10Y*
8.36%

METL

1D
0.05%
1M
-9.97%
YTD
7.51%
6M
15.84%
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

SBIO vs. METL - Yearly Performance Comparison


2026 (YTD)2025
SBIO
ALPS Medical Breakthroughs ETF
-1.72%39.58%
METL
Sprott Active Metals & Miners ETF
7.51%28.19%

Correlation

The correlation between SBIO and METL is 0.32, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (All Time)
Calculated using the full available price history since Sep 10, 2025

0.32

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SBIO vs. METL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SBIO
SBIO Risk / Return Rank: 7373
Overall Rank
SBIO Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
SBIO Sortino Ratio Rank: 7070
Sortino Ratio Rank
SBIO Omega Ratio Rank: 6060
Omega Ratio Rank
SBIO Calmar Ratio Rank: 8888
Calmar Ratio Rank
SBIO Martin Ratio Rank: 7878
Martin Ratio Rank

METL
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SBIO vs. METL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ALPS Medical Breakthroughs ETF (SBIO) and Sprott Active Metals & Miners ETF (METL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SBIOMETLDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.33

Calmar ratioReturn relative to maximum drawdown

4.72

Martin ratioReturn relative to average drawdown

13.54

SBIO vs. METL - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


SBIOMETLDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.02

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.04

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.25

Sharpe Ratio (All Time)

Calculated using the full available price history

0.21

1.18

-0.96

Drawdowns

SBIO vs. METL - Drawdown Comparison

The maximum SBIO drawdown since its inception was -63.06%, which is greater than METL's maximum drawdown of -27.39%. Use the drawdown chart below to compare losses from any high point for SBIO and METL.


Loading charts...

Drawdown Indicators


SBIOMETLDifference

Max Drawdown

Largest peak-to-trough decline

-63.06%

-27.39%

-35.67%

Max Drawdown (1Y)

Largest decline over 1 year

-12.66%

Max Drawdown (3Y)

Largest decline over 3 years

-42.44%

Max Drawdown (5Y)

Largest decline over 5 years

-53.10%

Max Drawdown (10Y)

Largest decline over 10 years

-63.06%

Current Drawdown

Current decline from peak

-17.90%

-18.48%

+0.58%

Average Drawdown

Average peak-to-trough decline

-28.43%

-8.24%

-20.19%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.40%

Volatility

SBIO vs. METL - Volatility Comparison


Loading charts...

Volatility by Period


SBIOMETLDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.87%

Volatility (6M)

Calculated over the trailing 6-month period

22.68%

Volatility (1Y)

Calculated over the trailing 1-year period

29.62%

44.85%

-15.23%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

33.56%

44.85%

-11.29%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

33.18%

44.85%

-11.67%

SBIO vs. METL - Expense Ratio Comparison

SBIO has a 0.50% expense ratio, which is lower than METL's 0.89% expense ratio.


Dividends

SBIO vs. METL - Dividend Comparison

SBIO has not paid dividends to shareholders, while METL's dividend yield for the trailing twelve months is around 0.92%.


PositionTTM202520242023202220212020201920182017
METL
Sprott Active Metals & Miners ETF
0.92%0.99%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SBIO
ALPS Medical Breakthroughs ETF
0.00%0.00%3.55%0.22%0.00%0.00%0.00%0.04%2.79%1.77%

Frequently Asked Questions


SBIO and METL have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, SBIO is cheaper at 0.50% per year. The better choice depends on whether you care most about return, fees, risk, or income.

SBIO is cheaper with a 0.50% expense ratio, compared with 0.89% for METL.

METL has the higher dividend yield at 0.92%, compared with 0.00% for SBIO.

SBIO is categorized as Health & Biotech Equities, while METL is Commodity Producers Equities. They also come from different issuers: SS&C and Sprott. Their fees differ too: 0.50% for SBIO and 0.89% for METL.

Portfolio Optimizer

Find the right allocation for SBIO and METL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer